244 related articles for article (PubMed ID: 17762241)
1. Old antibiotics for infections in critically ill patients.
Falagas ME; Kopterides P
Curr Opin Crit Care; 2007 Oct; 13(5):592-7. PubMed ID: 17762241
[TBL] [Abstract][Full Text] [Related]
2. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections.
Falagas ME; Kasiakou SK
Clin Infect Dis; 2005 May; 40(9):1333-41. PubMed ID: 15825037
[TBL] [Abstract][Full Text] [Related]
3. Intravenous fosfomycin for the treatment of nosocomial infections caused by carbapenem-resistant Klebsiella pneumoniae in critically ill patients: a prospective evaluation.
Michalopoulos A; Virtzili S; Rafailidis P; Chalevelakis G; Damala M; Falagas ME
Clin Microbiol Infect; 2010 Feb; 16(2):184-6. PubMed ID: 19694767
[TBL] [Abstract][Full Text] [Related]
4. Local administration of polymyxins into the respiratory tract for the prevention and treatment of pulmonary infections in patients without cystic fibrosis.
Falagas ME; Kasiakou SK
Infection; 2007 Feb; 35(1):3-10. PubMed ID: 17297582
[TBL] [Abstract][Full Text] [Related]
5. Colistin and polymyxin B in critical care.
Michalopoulos A; Falagas ME
Crit Care Clin; 2008 Apr; 24(2):377-91, x. PubMed ID: 18361952
[TBL] [Abstract][Full Text] [Related]
6. New information about the polymyxin/colistin class of antibiotics.
Molina J; Cordero E; Pachón J
Expert Opin Pharmacother; 2009 Dec; 10(17):2811-28. PubMed ID: 19929704
[TBL] [Abstract][Full Text] [Related]
7. Potential of old-generation antibiotics to address current need for new antibiotics.
Falagas ME; Grammatikos AP; Michalopoulos A
Expert Rev Anti Infect Ther; 2008 Oct; 6(5):593-600. PubMed ID: 18847400
[TBL] [Abstract][Full Text] [Related]
8. Aerosolized colistin as adjunctive treatment of ventilator-associated pneumonia due to multidrug-resistant Gram-negative bacteria: a prospective study.
Michalopoulos A; Fotakis D; Virtzili S; Vletsas C; Raftopoulou S; Mastora Z; Falagas ME
Respir Med; 2008 Mar; 102(3):407-12. PubMed ID: 18060758
[TBL] [Abstract][Full Text] [Related]
9. Resistance in nonfermenting gram-negative bacteria: multidrug resistance to the maximum.
McGowan JE
Am J Infect Control; 2006 Jun; 34(5 Suppl 1):S29-37; discussion S64-73. PubMed ID: 16813979
[TBL] [Abstract][Full Text] [Related]
10. Adjunctive aerosolized antibiotics for treatment of ventilator-associated pneumonia.
Czosnowski QA; Wood GC; Magnotti LJ; Croce MA; Swanson JM; Boucher BA; Fabian TC
Pharmacotherapy; 2009 Sep; 29(9):1054-60. PubMed ID: 19698010
[TBL] [Abstract][Full Text] [Related]
11. A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae.
Vasilev K; Reshedko G; Orasan R; Sanchez M; Teras J; Babinchak T; Dukart G; Cooper A; Dartois N; Gandjini H; Orrico R; Ellis-Grosse E;
J Antimicrob Chemother; 2008 Sep; 62 Suppl 1():i29-40. PubMed ID: 18684704
[TBL] [Abstract][Full Text] [Related]
12. Colistin serum concentrations after intravenous administration in critically ill patients with serious multidrug-resistant, gram-negative bacilli infections: a prospective, open-label, uncontrolled study.
Markou N; Markantonis SL; Dimitrakis E; Panidis D; Boutzouka E; Karatzas S; Rafailidis P; Apostolakos H; Baltopoulos G
Clin Ther; 2008 Jan; 30(1):143-51. PubMed ID: 18343250
[TBL] [Abstract][Full Text] [Related]
13. Role of old antibiotics in multidrug resistant bacterial infections.
Maviglia R; Nestorini R; Pennisi M
Curr Drug Targets; 2009 Sep; 10(9):895-905. PubMed ID: 19799544
[TBL] [Abstract][Full Text] [Related]
14. Fosfomycin: use beyond urinary tract and gastrointestinal infections.
Falagas ME; Giannopoulou KP; Kokolakis GN; Rafailidis PI
Clin Infect Dis; 2008 Apr; 46(7):1069-77. PubMed ID: 18444827
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of isepamicin and other aminoglycosides against clinical isolates of Gram-negative bacteria causing nosocomial bloodstream infections.
Tsai TY; Chang SC; Hsueh PR; Feng NH; Wang JT
J Microbiol Immunol Infect; 2007 Dec; 40(6):481-6. PubMed ID: 18087627
[TBL] [Abstract][Full Text] [Related]
16. [Resistance to newer beta-lactams and related ESBL types in gram-negative nosocomial isolates in Turkish hospitals: results of the multicentre HITIT study].
Gür D; Gülay Z; Akan OA; Aktaş Z; Kayacan CB; Cakici O; Eraç B; Gültekin M; Oğünç D; Söyletir G; Unal N; Uysal S
Mikrobiyol Bul; 2008 Oct; 42(4):537-44. PubMed ID: 19149074
[TBL] [Abstract][Full Text] [Related]
17. Confronting the threat of multidrug-resistant Gram-negative bacteria in critically ill patients.
Cohen J
J Antimicrob Chemother; 2013 Mar; 68(3):490-1. PubMed ID: 23152481
[TBL] [Abstract][Full Text] [Related]
18. Revival of old antibiotics: needs, the state of evidence and expectations.
Zayyad H; Eliakim-Raz N; Leibovici L; Paul M
Int J Antimicrob Agents; 2017 May; 49(5):536-541. PubMed ID: 28162982
[TBL] [Abstract][Full Text] [Related]
19. Intravenous colistimethate (colistin) use in critically ill children without cystic fibrosis.
Falagas ME; Sideri G; Vouloumanou EK; Papadatos JH; Kafetzis DA
Pediatr Infect Dis J; 2009 Feb; 28(2):123-7. PubMed ID: 19116601
[TBL] [Abstract][Full Text] [Related]
20. Acinetobacter baumannii: an emerging multidrug-resistant threat.
Gootz TD; Marra A
Expert Rev Anti Infect Ther; 2008 Jun; 6(3):309-25. PubMed ID: 18588496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
